Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China flag China · Delayed Price · Currency is CNY
33.80
-0.06 (-0.18%)
At close: Feb 6, 2026

SHE:301108 Revenue

Tongling Jieya Biologic Technology had revenue of 254.65M CNY in the quarter ending September 30, 2025, with 107.21% growth. This brings the company's revenue in the last twelve months to 704.26M, up 20.74% year-over-year. In the year 2024, Tongling Jieya Biologic Technology had annual revenue of 547.45M, down -12.07%.

Revenue (ttm)
704.26M
Revenue Growth
+20.74%
P/S Ratio
5.40
Revenue / Employee
1.14M
Employees
618
Market Cap
3.80B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024547.45M-75.14M-12.07%
Dec 31, 2023622.59M-43.98M-6.60%
Jan 1, 2023666.56M-317.89M-32.29%
Jan 1, 2022984.45M241.44M32.49%
Dec 31, 2020743.01M435.60M141.70%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition